TITAN BIOTECH
|
|
BOM : 524717     NSE :      | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
May 25,2022 |
Price(EOD): ₹ 233.35
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Chemicals |
MCap: ₹ 193.68 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
TITAN BIOTECH | -3.7% | -13% | -20.8% |
PIDILITE INDUSTRIES | 1% | -11.2% | 9.9% |
AARTI INDUSTRIES | -0.6% | -16.5% | -9.1% |
DEEPAK NITRITE | -6.9% | -18.2% | 11% |
ATUL | -2.8% | -18.3% | -5.8% |
ALKYL AMINES CHEMICALS | -7.3% | -16.9% | -24.5% |
TATA CHEMICALS | -3.2% | -1.7% | 36.1% |
NAVIN FLUORINE INTERNATIONAL | -5.9% | -10.2% | 16.3% |
GODREJ INDUSTRIES | -3.5% | -9.8% | -20.7% |
FUNDAMENTAL ANALYSIS OF TITAN BIOTECH
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF TITAN BIOTECH
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
6.36
P/E Calculated based on EPS of 36.71
[ Mar2021 - Consolidated Results ] 2.8
P/B Calculated based on Book Value of 83.21
[ Mar2021 - Consolidated Results ] 1.26
P/S Calculated based on Revenues of 153.825 Cr
[ TTM - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
164% 64% 70% |
SHARE PRICE MOMENTUM OF TITAN BIOTECH
TITAN BIOTECH vs SENSEX
DEBT OF TITAN BIOTECH
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2021 2020 2019 Avg_3yrs |
0.13 0.47 0.68 0.43 |
0.21 0.61 0.74 0.52 |
[Last Annual Data : Mar2021]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF TITAN BIOTECH
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Mar2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF TITAN BIOTECH
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-11.97% -17.02% -18.34% -21.91% |
3.95% -11.04% -12.64% -12.84% |
QtrlyTrend |
-6 | |
Latest Qtr: Dec2021 | ||
Quarterly Result Analysis → |
TITAN BIOTECH related INDICES
You may also like the below Video Courses
FAQ about TITAN BIOTECH
Is TITAN BIOTECH good for long term investment?
As on May 25,2022, the Fundamentals of TITAN BIOTECH look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of TITAN BIOTECH . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is TITAN BIOTECH UnderValued or OverValued?
As on May 25,2022, TITAN BIOTECH is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of TITAN BIOTECH ?
As on May 25,2022, the Intrinsic Value of TITAN BIOTECH is Rs. 137.10 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 88.35
Fair Value [Median EV / Sales Model] : Rs. 142.12
Fair Value [Median Price / Sales Model] : Rs. 137.10
Median Fair Value of TITAN BIOTECH : Rs. 137.10
Is TITAN BIOTECH trading at a Premium or Discount?
As on May 25,2022, TITAN BIOTECH is trading at a Premium of 70% based on the estimates of Median Intrinsic Value!PIDILITE INDUSTRIES LTD vs AARTI INDUSTRIES LTD vs DEEPAK NITRITE LTD
ATUL LTD vs ALKYL AMINES CHEMICALS LTD vs TATA CHEMICALS LTD
NAVIN FLUORINE INTERNATIONAL LTD vs GODREJ INDUSTRIES LTD vs GUJARAT FLUOROCHEMICALS LTD
VINATI ORGANICS LTD vs CLEAN SCIENCE AND TECHNOLOGY LTD vs SOLAR INDUSTRIES INDIA LTD
BALAJI AMINES LTD vs LAXMI ORGANIC INDUSTRIES LTD vs FINE ORGANIC INDUSTRIES LTD
